Gross Claudia, Engleitner Thomas, Lange Sebastian, Weber Julia, Jesinghaus Moritz, Konukiewitz Björn, Muckenhuber Alexander, Steiger Katja, Pfarr Nicole, Goeppert Benjamin, Keller Gisela, Weichert Wilko, Adsay Nazmi Volkan, Klöppel Günter, Rad Roland, Esposito Irene, Schlitter Anna Melissa
Institute of Pathology, School of Medicine, Technische Universität München, 81675 Munich, Germany.
Institute of Molecular Oncology and Functional Genomics, TUM School of Medicine, Technische Universität München, 81675 Munich, Germany.
Cancers (Basel). 2021 Jun 1;13(11):2742. doi: 10.3390/cancers13112742.
The molecular carcinogenesis of intraductal tubulopapillary neoplasms (ITPN), recently described as rare neoplasms in the pancreato-biliary tract with a favorable prognosis despite a high incidence of associated pancreato-biliary adenocarcinoma, is still poorly understood. To identify driver genes, chromosomal gains and losses, mutational signatures, key signaling pathways, and potential therapeutic targets, the molecular profile of 11 biliary and 6 pancreatic ITPNs, associated with invasive adenocarcinoma in 14/17 cases, are studied by whole exome sequencing (WES). The WES of 17 ITPNs reveals common copy number variants (CNVs) broadly distributed across the genome, with recurrent chromosomal deletions primarily in 1p36 and 9p21 affecting the tumor suppressors and , respectively, and gains in 1q affecting the prominent oncogene . The identified somatic nucleotide variants (SNVs) involve few core signaling pathways despite high genetic heterogeneity with diverse mutational spectra: Chromatin remodeling, the cell cycle, and DNA damage/repair. An OncoKB search identifies putative actionable genomic targets in 35% of the cases (6/17), including recurrent missense mutations of the gene in biliary ITPNs (2/11, 18%). Our results show that somatic SNV in classical cancer genes, typically associated with pancreato-biliary carcinogenesis, were absent (, , , and others) to rare ( and , 6%, respectively) in ITPNs. Mutational signature pattern analysis reveals a predominance of an age-related pattern. Our findings highlight that biliary ITPN and classical cholangiocarcinoma display commonalities, in particular mutations in genes of the chromatin remodeling pathway, and appear, therefore, more closely related than pancreatic ITPN and classical pancreatic ductal adenocarcinoma.
导管内管状乳头状肿瘤(ITPN)的分子致癌机制目前仍知之甚少。ITPN是最近在胰胆管中发现的罕见肿瘤,尽管其合并胰胆管腺癌的发生率很高,但预后良好。为了确定驱动基因、染色体的增减、突变特征、关键信号通路和潜在的治疗靶点,我们通过全外显子组测序(WES)研究了11例胆管和6例胰腺ITPN的分子特征,其中14/17例与浸润性腺癌相关。17例ITPN的WES显示,常见的拷贝数变异(CNV)广泛分布于整个基因组,主要是1p36和9p21的反复染色体缺失,分别影响肿瘤抑制因子 和 ,以及1q的增加影响著名的癌基因 。尽管存在高度的遗传异质性和多样的突变谱,但所鉴定的体细胞核苷酸变异(SNV)仅涉及少数核心信号通路:染色质重塑、细胞周期和DNA损伤/修复。OncoKB搜索在35%的病例(6/17)中确定了推定的可操作基因组靶点,包括胆管ITPN中 基因的反复错义突变(2/11,18%)。我们的结果表明,在ITPN中,经典癌症基因中的体细胞SNV通常与胰胆管致癌作用相关,要么不存在( 、 、 等),要么很少见( 和 ,分别为6%)。突变特征模式分析显示与年龄相关的模式占主导地位。我们的研究结果突出表明,胆管ITPN与经典胆管癌有共同之处,特别是在染色质重塑途径基因中的突变,因此,它们之间的关系似乎比胰腺ITPN与经典胰腺导管腺癌更为密切。